NewAmsterdam Pharma Company N.V. Warrants share price logo

NewAmsterdam Pharma Company N.V. Warrants

NASDAQ: NAMSW

$24.89

+1.45

(+6.19%)

as on

NewAmsterdam Pharma Company N.V. Warrants Stock Performance

as on July 8, 2026 at 6:51 am IST

  • Day's Low

    $23.94
    $24.89
    downward going graph

    3.82%

    Downside

  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

NewAmsterdam Pharma Company N.V. Warrants share price movements today

Previous Close
$23.44
Open
$23.94
Volume
25.3K
Day's Low - High
$23.94 - $24.89

NewAmsterdam Pharma Company N.V. Warrants Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

NewAmsterdam Pharma Company N.V. Warrants Stock Fundamentals & Key Indicators

Check NewAmsterdam Pharma Company N.V. Warrants market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-29.49%

NewAmsterdam Pharma Company N.V. Warrants stock Key Stats

Compare market cap, revenue, PE, and other key metrics of NewAmsterdam Pharma Company N.V. Warrants with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NewAmsterdam Pharma Company N.V. Warrants image
NewAmsterdam Pharma Company N.V. Warrants
NA$-NANA0.00%NA

NewAmsterdam Pharma Company N.V. Warrants Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
1
2
29
12
2
19
0
0
3
Gross Profit
0
1
2
29
12
2
19
0
0
2
Operating Income
-51
-55
-52
-25
-43
-68
-35
-55
-65
-58
EBITDA
-50
-93
-51
-23
-111
-39
-17
-71
-74
-48
Interest Expense
1
0
0
1
3
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-49
-93
-39
-16
-92
-39
-17
-72
-74
-48
Income Tax Expense
0
-3
-12
0
-
-
-
-
-
-
Net Income
-49
-93
-39
-16
-92
-39
-17
-72
-74
-48
Net Profit Margin
-6163.76%
-6692.86%
-1711.58%
-57.18%
-721.71%
-1327.30%
-90.70%
-20691.09%
-234134.38%
-1593.45%

NewAmsterdam Pharma Company N.V. Warrants Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
108
14
45
22
Gross Profit
-
0
108
14
45
22
Operating Income
-6
-34
-3
-182
-176
-225
EBITDA
-6
-41
-22
-176
-241
-242
Interest Expense
0
0
0
6
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
-7
-41
-22
-176
-241
-203
Income Tax Expense
0
0
70
0
0
-
Net Income
-8
-47
-23
-176
-241
-203
Net Profit Margin
0.00%
0.00%
-22.04%
-1255.76%
-530.25%
-905.74%

NewAmsterdam Pharma Company N.V. Warrants Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-93
-39
-16
-92
-39
-17
39
-74
-48
Operating Cash Flow
-54
-53
-12
-37
-36
-37
-32
-40
-30
Investing Cash Flow
0
0
0
-62
2
-159
2
-21
-11
Financing Cash Flow
198
4
0
456
6
3
5
13
11
Change in Cash
140
-50
-7
349
-23
-184
-24
-48
-32

NewAmsterdam Pharma Company N.V. Warrants Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-41
-22
-176
-241
-203
Operating Cash Flow
-29
10
-141
-158
-147
Investing Cash Flow
0
0
0
-62
-174
Financing Cash Flow
84
391
8
659
29
Change in Cash
50
407
-127
431
-280

About NewAmsterdam Pharma Company N.V. Warrants

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
OrganisationNewAmsterdam Pharma Company N.V. Warrants
HeadquartersGooimeer 2-35, Naarden, Netherlands, 1411 DC
IndustryHealth Care
CEODr. Michael Harvey Davidson FACC, Facp., M.D.
E-voting on sharesClick here to vote

Key Management of NewAmsterdam Pharma Company N.V. Warrants

Name

Title

Ms. Juliette Audet M.B.A., M.Sc.

Chief Strategy & Business Officer

Mr. Mayur Amrat Somaiya

Chief Financial Officer

Mr. Douglas F. Kling

Chief Operating Officer

Ms. Louise Kooij

Chief Accounting Officer

Mr. Matthew Philippe

Executive VP & Head of Investor Relations

Mr. Michael F. Marino Esq.

Chief Legal Officer & Corporate Secretary

Mr. Chris Deluzio

Executive Vice President of Sales Enterprise Operations

Dr. Michael Harvey Davidson FACC, Facp., M.D.

CEO, President & Executive Director

Dr. Johannes Jacob Pieter Kastelein FESC, M.D., Ph.D.

Founder, Chief Scientific Officer, Member of Executive Board & Director

Ms. Maryellen McQuade

Chief People Officer

FAQs

What is NewAmsterdam Pharma Company N.V. Warrants share price today?

NewAmsterdam Pharma Company N.V. Warrants share price today is $24.89 as on at the close of the market. NewAmsterdam Pharma Company N.V. Warrants share today touched a day high of $24.89 and a low of $23.94.

What is the 52 week high and 52 week low for NewAmsterdam Pharma Company N.V. Warrants share?

NewAmsterdam Pharma Company N.V. Warrants share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . NewAmsterdam Pharma Company N.V. Warrants stock price today i.e. is closed at $24.89,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

How to invest in NewAmsterdam Pharma Company N.V. Warrants Stock (NAMSW) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for NewAmsterdam Pharma Company N.V. Warrants on INDmoney app. Click on Buy button. You can invest as low as $1.5 in NewAmsterdam Pharma Company N.V. Warrants Shares that will get you 0.0603 shares as per NewAmsterdam Pharma Company N.V. Warrants share price of $24.89 per share as on July 8, 2026 at 1:21 am IST.

What is the minimum amount required to buy NewAmsterdam Pharma Company N.V. Warrants Stock (NAMSW) from India?

Indian investors can start investing in NewAmsterdam Pharma Company N.V. Warrants (NAMSW) shares with as little as ₹94.9675 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.67 in NewAmsterdam Pharma Company N.V. Warrants stock (as per the Rupee-Dollar exchange rate as on ). Based on NewAmsterdam Pharma Company N.V. Warrants share’s latest price of $24.89 as on July 8, 2026 at 1:21 am IST, you will get 0.4018 shares of NewAmsterdam Pharma Company N.V. Warrants. Learn more about fractional shares .